http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2148994-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_438294183a4c9c9f50e7d23b42da5283 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 1998-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05391b6ac27c45063368432ab936dc8b |
| publicationDate | 2000-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2148994-C1 |
| titleOfInvention | Method of treatment of women with acne disease |
| abstract | FIELD: medicine, dermatology. SUBSTANCE: invention proposes oral administration of bromocriptine at the dose 5.0-7.5 mg per 24 h and α-thyroxine at the dose 25-75 mg per 24 h for total treatment course. Also, in addition to basic preparation antistrumin is prescribed at the dose 2000 mg per a week orally for 3-6 months and vitamin E by intramuscular route at the dose 1.0 ml for 20 days. EFFECT: enhanced effectiveness of treatment, stable remission, decreased probability of adverse responses. 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2495675-C1 |
| priorityDate | 1998-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.